Useful Article On Genetics Ivf Institute
Genetics Ivf Institute Article
This is a selection made from among articles on Genetics Ivf Institute. For a permanent link to this article, or to bookmark it for future reading, click here.
Addressing Issues Relating to Free IVF Procedures
from:In vitro fertilization has become one of the top choices when it comes to assisted reproduction. It is a procedure that allows fertilization of the eggs outside the woman's uterus by facilitating the retrieval of the egg from the female and the semen from the male participant. These will then be fused in a laboratory dish before the transplantation of the fertilized egg in the woman's uterus.
Unlike with the usual manner of fertilization, the embryo that will be produced (if the participants are lucky enough) is limited to one. With in vitro fertilization treatment, the embryos that will be implanted in the female participant will range from 2 to four. Thus, the possibility of miscarriage and multiple pregnancy.
Although many may pose their disagreements on this method, it cannot be denied that most couple (if only they can afford a cycle or two perhaps) would automatically jump to the chance of having a free in vitro fertilization.
This concept of giving away "slots for free IVF" has become one of the most in demand issues in the States, as well as in the United Kingdom. In fact, there are government plans in Great Britain that propose free IVF for women aged 23 to 39. However, they must have pre-diagnosed cause of infertility. Yet the availability of the free IVF is applicable for women with unexplained infertility as well. Free in vitro fertilization program would be limited to three free cycles, according to the guidelines as proposed by National Institute of Clinical Excellence or NICE.
Nonetheless, there are still no assurance that the British government will approve this proposal. This is mainly because of the possibility that if this plan materializes, the government would have to allocate huge budget for the project. Additionally, the problem that "will the government cope with the ever-increasing demand?" is also becoming an implied question. Similar projects in Europe have caused increasing demands for IVF treatments.
If the same government scheme will be applied in the United States then our government might not be able to support the general public's demand. This may be caused partly by infertile couples who haven't undergone private IVF treatments and those who would rather switch to free IVF than shoulder their personal expenses
The average price of in vitro fertilization is high and there are no assurances that the "average" price is really what the reality may pose.
IVF cost always vary from place to place, situation to situation and from personal factors to another. Though there may be data that will help us estimate the actual cost of each cycle, these still cannot give the real market value. There are too many factors that may affect the cost of IVF and that's one issue that most couples would often not want to face.
Usually, a couple needs to repeat a cycle if the first or the second attempt didn't work. This often happens with in vitro fertilization. Again, there are too many underlying factors that may dictate the outcome of the conception of the child. And such mishaps will lead to only two things: to drop the idea altogether or continue the same process and spend thousands of dollars for a second chance.
It must be understood though that in vitro fertilization seems only to work for half of all patients. Not all infertile women conceive successfully and not all who were able to conceive can really produce a baby. There are too many dangers in pregnancy, especially when the fertilization of the eggs is made via in vitro fertilization, free or not.
 |
 |
Genetics Ivf Institute News
NIH grants fund to complete two floors at Texas Children's Hospital
Neurological research at Baylor College of Medicine (BCM) and Texas Children's Hospital is getting a big boost in the form of a $14.85 million grant from the National Institutes of Health (NIH) to complete two floors of the Jan and Dan Duncan Neurological Research Institute (NRI) at Texas Children's Hospital.
Read more...Why The MRC Didn't Fund Research That Led To The Birth Of The World's First Test Tube Baby
Thirty-two years ago today, the world's first baby was born after in vitro fertilisation. However, the work that led to the birth of Louise Brown on 25 July 1978 had to be privately funded after the UK's Medical Research Council decided in 1971 against providing the Cambridge physiologist Robert Edwards and the Oldham gynaecologist Patrick Steptoe with long-term financial support. Today, an ...
Read more...Why Did In Vitro Fertilization Occur Without Any Public Funding?
On 25th July, 1978 Louise Brown, the first in vitro fertilization baby was born thanks to privately funded research carried out by the Cambridge (UK) physiologist Robert Edwards and the Oldham (UK) gynecologist Patrick Steptoe. The whole thing was privately funded because the Medical Research Council (MRC), UK turned down a request for long-term financial support in 1971. Today, an interesting ...
Read more...IVF: The uncomfortable truth
Fertility expert Dr Gedis Grudzinskas is famously blunt with his patients. He is also highly sceptical about the industry that has grown up around making babies and believes we put too much faith in medical solutions Dr Gedis Grudzinskas is one of the most respected names in fertility. He is angry. Fed up of potential patients being given false hope by the baby-making industry, he is distinctly ...
Read more...Fact or Fiction: Artificial Reproductive Technologies Make Sick Kids
Most children conceived via assisted reproductive technology (ART), such as superovulation are fine, although some recent studies are raising doubts about whether these fertility fixes are as safe as promised. The extensive handling of these crucial cells is a concern, and there are mixed reports on the long-term health of these hard-won children, with several studies suggesting increased risks ...
Read more...Rubicon Genomics' PicoPlex Linear Amplification Technology Enables Successful International Clinical Genetic Study Of ...
Rubicon Genomics announced that its PicoPlex linear whole genome amplification (WGA) technology was proven to be effective in an independent clinical study organized by the European Society for Human Reproduction and Embryology (ESHRE). At a press conference during its 26th Annual Meeting in Rome, ESHRE reported the success of its "groundbreaking proof of principle study" showing that a new ...
Read more...